In the Media

Filter media by keyword

Filter media by  Investigators  Clear filters

Two PrEP Meds Work Equally Well; One Is Much Cheaper
HealthDay
Two PrEP Meds Work Equally Well; One Is Much Cheaper
Non-Daily PrEP Survey Creates More Questions
Medpage Today
Non-Daily PrEP Survey Creates More Questions
Should PrEP Users Switch From Truvada to Descovy?
MedPage Today
Should PrEP Users Switch From Truvada to Descovy?
Uptick in Statin Use After Descovy in HIV PrEP
Medscape
Uptick in Statin Use After Descovy in HIV PrEP
Your PrEP Is Not a Status Symbol
Slate
Your PrEP Is Not a Status Symbol
Experts Say Truvada Should Remain First Choice in Pre-exposure Prophylaxis for Most Patients with Risk of HIV
Pharmacy Times
Experts Say Truvada Should Remain First Choice in Pre-exposure Prophylaxis for Most Patients with Risk of HIV
Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’
TheBodyPro
Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’
Commentary Argues for Keeping TDF/FTC as First-Line PrEP
ContagionLive
Commentary Argues for Keeping TDF/FTC as First-Line PrEP
Truvada Should Remain First Choice for PrEP, Experts Argue
POZ Magazine
Truvada Should Remain First Choice for PrEP, Experts Argue